SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-046415
Filing Date
2014-07-08
Accepted
2014-07-08 16:26:38
Documents
1
Period of Report
2014-07-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 17502
  Complete submission text file 0001209191-14-046415.txt   19622
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Reporting) CIK: 0000816284 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35642 | Film No.: 14965672
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 3036252744
GLOBEIMMUNE INC (Issuer) CIK: 0001245104 (see all company filings)

IRS No.: 841353925 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 86 MORRIS AVENUE C/O CELGENE CORP SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE C/O CELGENE CORP SUMMIT NJ 07901 908-673-9000
Celgene International Inc (Reporting) CIK: 0001558852 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35642 | Film No.: 14965673